01:01 PM EDT, 10/30/2025 (MT Newswires) -- (Updates with the stock move in the headline and first paragraph.)

Guardant Health ( GH ) shares jumped nearly 30% in recent Thursday trading after the company reported overnight better-than-expected Q3 results and raised its full-year revenue forecast.

The company reported a Q3 adjusted loss late Wednesday of $0.39 per diluted share, narrower than a loss of $0.45 a year earlier.

Analysts polled by FactSet expected a non-GAAP loss of $0.47.

Revenue for the quarter ended Sept. 30 was $265.2 million, up from $191.5 million a year ago. Analysts surveyed by FactSet expected $235.6 million.

For 2025, the company now expects revenue to be in a range of $965 million to $970 million, up from its previous outlook of $915 million to $925 million. Analysts polled by FactSet expect $936.6 million.

Price: 93.86, Change: +21.59, Percent Change: +29.87